BeautyHealth Stock Plunge: Overreaction or Real Trouble?
Update: 2025-09-10
Description
BeautyHealth stock plunges as a rival gets FDA approval for a new injectable, but is it an overreaction? Find out why investors are nervous about the beauty market, the volatility of BeautyHealth's stock, and why long-term trends and booming online sales might mean this dip is just a blip.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
